Sylentis
Manufacturing · Spain · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2 C/ Santiago Grisolía, Madrid, Madrid, ...Phone Number
+34 918047667Website
www.sylentis.comRevenue
$5.5 MillionIndustry
About Sylentis
Is Sylentis your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Sylentis launches new products
Check out if Sylentis is spiking on competitors!
Check if Sylentis has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Sylentis
Funding: Get notified immidiatlly once Sylentis has new funding data
Sylentis, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if Sylentis had a recent Job posting/layoffs
Earning: See what the market has to say on Sylentis recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Sylentis is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sylentis is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sylentis.
Sylentis Tech Stack
A closer look at the technologies used by Sylentis
Most Recent Scoops
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sylentis
Sylentis is a biopharmaceutical company specializing in RNA interference (RNAi) technology aimed at improving eye health. Their innovative products, including Tivanisiran for dry eye syndrome and SYL1801 for age-related macular degeneration, are designed to target and silence specific genes responsible for ocular diseases. The company also offers c... Read More